Construction and evaluation of a virG thyA double mutant of Shigella flexneri 2a as a candidate live-attenuated oral vaccine

By Yoshikawa M.   Sasakawa C.   Okada N.   Takasaka M.   Nakayama M.   Yoshikawa Y.   Kohno A.   Danbara H.   Nariuchi H.   Shimada H.   Toriumi M.  

Vaccine, Vol. 13, Iss. 15, 1995-01 ,pp. : 1436-1440

Elsevier

Access to resources Recommend Favorite

Potency testing of a live, genetically attenuated vaccine for salmonids

By Marsden M.J.   Vaughan L.M.   Fitzpatrick R.M.   Foster T.J.   Secombes C.J.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1087-1094

Elsevier

Access to resources Recommend Favorite

Further evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humans

By Mao J.S.   Chai S.A.   Xie R.Y.   Chen N.L.   Jiang Q.   Zhu X.Z.   Zhang S.Y.   Huang H.Y.   Mao H.W.   Bao X.N.   Liu C.J.  

Vaccine, Vol. 15, Iss. 9, 1997-06 ,pp. : 944-947

Elsevier

Access to resources Recommend Favorite

Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine

By Rothman A.L.   Kanesa-thasan N.   West K.   Janus J.   Saluzzo J.-F.   Ennis F.A.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4694-4699

Elsevier

Access to resources Recommend Favorite

guaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin

By Anderson R.J.   Pasetti M.F.   Sztein M.B.   Levine M.M.   Noriega F.R.  

Vaccine, Vol. 18, Iss. 21, 2000-04 ,pp. : 2193-2202

Elsevier

Access to resources Recommend Favorite